| Mr Edward Odilon Cyr, CRNA, MSN | |
|
47 Franca Dr, Bristol, RI 02809-4712 | |
| (401) 254-2618 | |
| Not Available |
| Full Name | Mr Edward Odilon Cyr |
|---|---|
| Gender | Male |
| Speciality | Nurse Anesthetist, Certified Registered |
| Location | 47 Franca Dr, Bristol, Rhode Island |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1457320335 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367500000X | Nurse Anesthetist, Certified Registered | 130129 (Massachusetts) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Mr Edward Odilon Cyr, CRNA, MSN 47 Franca Dr, Bristol, RI 02809-4712 Ph: (401) 254-2618 | Mr Edward Odilon Cyr, CRNA, MSN 47 Franca Dr, Bristol, RI 02809-4712 Ph: (401) 254-2618 |
News Archive
Continuous data collection for chronic illness management is crucial to deliver personalized care for patients. In the era of globalization, patients still do not have the right tools to collect and share their physiological information on a frequent, real time basis.
Sartorius Stedim Biotech and Penn State University have entered into a collaborative partnership to advance multidisciplinary teaching and research in biotechnology. This long-term relationship will support the education and preparation of the next generation of biotechnology leaders.
As a founding member, the Institute for Quality and Efficiency in Health Care (IQWiG) has been involved in EUnetHTA, a European network for Health Technology Assessment (HTA), since 2006.
A new initiative launched by the Institute for Clinical Systems Improvement, a nonprofit, health care improvement organization, could save the Minnesota health care community more than $28 million annually, as well as improve patient care and provider groups' productivity.
On 24 January 2020, the first imported cases (3) of 2019-nCoV were identified in France. The rapid increase in the number of reported cases can be partly attributed to the ongoing improved testing protocols and epidemiological investigations of the Chinese authorities; however, since the original source remains unknown and human-to-human transmission has been documented, further cases and deaths are expected.
› Verified 4 days ago